FDA Says Shortages of GLP-1 Drugs Mounjaro and Zepbound Are Over
Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for more than two years. But the drugmaker Eli Lilly is “currently meeting or exceeding demand” for all doses of these medicines and should continue to do so going forward, the FDA said in a December 19 statement.
The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes ...
From pig kidney transplants to the development of a new schizophrenia drug, here are five of the biggest medical ...
The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...
Merck will discontinue its drug for a bacterial infection that can lead to fatal diarrhea, the U.S. Food and Drug ...
While eggs haven’t historically been considered a " health food ," the U.S. Food and Drug Administration (FDA) now classifies ...
The U.S. Food and Drug Administration redefined its parameters for “healthy” food for the first time in 30 years.
The agency recommended that the maker of Librela update its label to reflect the possibility of more serious adverse reactions.
If your drug trials don't succeed, try again with another drug — and raise more money. That's $RAPT's plan as it targets food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback